Eprontia (topiramate) conversion

PLEASE NOTE:   Posts made to this forum should not be considered as the expressed opinions of, nor should be considered endorsed by, the Medication Safety Officer’s Society (MSOS) or the Institute for Safe Medication Practices (ISMP). 

Make sure your email is up-to-date
In order to continue to receive updates from MSOS, as well as forum posts and other valuable information as a member of MSOS, please be sure to update your email address with us, whenever it changes. If you need assistance doing so, please send an email to jgold@ismp.org

3 posts / 0 new
Last post
Kathleen Neves
Kathleen Neves's picture
Offline
Last seen: 1 week 2 days ago
Joined: 07/01/2019 - 12:25
Eprontia (topiramate) conversion

Our organization is in the process of converting all outpatient and inpatient topiramate oral solutions over the the new commercially available product. We use Epic as our EMR and wondering what safety measures other organizations have used to make this a safe transition.

On the in-patient units we were compounding to 20 mg/mL to match ASHP Standardize-4-Safety, but our out-patient pharmacy within the same organization was compounding to 6 mg/mL as requested by a pediatric neurology clinic that writes most of our prescriptions.

Any help or advice is appreciated.